Bausch & Lomb director granted 15,842 RSUs

COLLIS STEVEN H reported acquisition or exercise transactions in this Form 4 filing.

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

COLLIS STEVEN H reported acquisition or exercise transactions in this Form 4 filing.

Bausch & Lomb Corp director Steven H. Collis received an equity award rather than buying shares on the market. He was granted 15,842 common-share-equivalent restricted share units (RSUs) valued at $15.78 per unit, bringing his direct holdings to 42,003 common shares after the award.

The RSUs were granted as the annual award to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. They are scheduled to vest on the date immediately before the company’s next annual meeting of shareholders, when they will be settled in common shares.

Insider Trade Summary

Grant/Award: 15,842 shares

Grant/Award 1 txn

Insider COLLIS STEVEN H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	15,842	$15.78	$250K

Holdings After Transaction: Common Shares, No Par Value — 42,003 shares (Direct)

Footnotes (1)

F1. Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.

Key Figures

RSUs granted: 15,842 units Grant value per RSU: $15.78 per unit Shares owned after grant: 42,003 shares +2 more

5 metrics

RSUs granted 15,842 units Annual equity grant to non-employee director

Grant value per RSU $15.78 per unit Reported transaction price per share-equivalent

Shares owned after grant 42,003 shares Direct common share holdings post-transaction

Transaction date 2026-05-26 Date of RSU grant to director

Transaction code A (grant/award acquisition) Indicates compensation-related share acquisition

Key Terms

restricted share units ("RSUs"), 2022 Omnibus Incentive Plan, annual meeting of shareholders

3 terms

2022 Omnibus Incentive Plan financial

"under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated"

annual meeting of shareholders financial

"The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bausch & Lomb (BLCO) director Steven H. Collis receive in this Form 4 filing?

Steven H. Collis received an equity compensation grant of 15,842 restricted share units (RSUs). These RSUs represent future common shares of Bausch & Lomb Corp and are part of the company’s regular annual awards to non-employee directors under its 2022 Omnibus Incentive Plan.

How large is the equity grant reported for BLCO director Steven H. Collis?

The grant totals 15,842 restricted share units valued at $15.78 per unit. This award increases his direct holdings to 42,003 common shares after the transaction, reflecting a sizable but routine director compensation grant rather than an open-market stock purchase.

Is the BLCO Form 4 transaction a stock purchase by Steven H. Collis?

No, the Form 4 reports a grant of restricted share units, not an open-market stock purchase. The award is classified as a grant, award, or other acquisition, typical of director compensation, and carries a specified value of $15.78 per RSU at the time of the grant.

When do the RSUs granted to BLCO director Steven H. Collis vest?

The RSUs are scheduled to vest on the date immediately preceding the conclusion of Bausch & Lomb’s next annual meeting of shareholders. At vesting, they will be settled in common shares of the company, converting the RSUs into freely owned stock for the director.

How many Bausch & Lomb common shares does Steven H. Collis hold after this Form 4 transaction?

Following the RSU grant, Steven H. Collis is reported to own 42,003 common shares directly. This figure includes the effect of the newly awarded restricted share units and reflects his total direct ownership position as disclosed in the Form 4 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/28/2026 - 05:02 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COLLIS STEVEN H

(Last)

(First)

(Middle)

C/O BAUSCH + LOMB CORPORATION

520 APPLEWOOD CRESCENT

(Street)

VAUGHAN

L4K 4B4

(City)

(State)

(Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares, No Par Value	05/26/2026		A		15,842⁽¹⁾	A	$15.78	42,003	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.

	/s/ Debra E. Levin, attorney-in-fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR